Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma

Breast cancer is a very heterogeneous disease. The intrinsic molecular subtypes can explain the intertumoral heterogeneity and the cancer stem cell (CSC) hypothesis can explain the intratumoral heterogeneity of this kind of tumor. CD44+/CD24- phenotype and ALDH1 expression are the major CSC markers...

Full description

Bibliographic Details
Main Authors: Iris Rabinovich, Ana Paula Martins Sebastião, Rubens Silveira Lima, Cícero de Andrade Urban, Eduardo Schunemann Junior, Karina Furlan Anselmi, Selene Elifio-Esposito, Lucia de Noronha, Andréa Novais Moreno-Amaral
Format: Article
Language:English
Published: PAGEPress Publications 2018-09-01
Series:European Journal of Histochemistry
Subjects:
Breast cancer
CD44 /CD24- phenotype
ALDH1
molecular subtypes
cancer stem cells
Online Access:https://ejh.it/index.php/ejh/article/view/2943

Internet

https://ejh.it/index.php/ejh/article/view/2943

Similar Items